Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
AGMB
AGMB
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
AGMB News
Universe Pharma Acquires Patent Portfolio, Shares Surge
Jun 30 2026
NASDAQ.COM
AgomAb Initiates Phase 2b Trial for Crohn's Disease Drug Ontunisertib
Jun 24 2026
NASDAQ.COM
AgomAb Therapeutics Reports Increased Losses for 2025
Apr 24 2026
seekingalpha
Agomab Reports 2025 Financial Results and Future Milestones
Apr 24 2026
NASDAQ.COM
Agomab's IPO Boosts Cash Runway into 2029
Apr 23 2026
Newsfilter
Wall Street Analysts Adjust Ratings
Mar 03 2026
Benzinga
Jennifer Garner's Once Upon a Farm Sees Nearly 20% Increase as IPO Week Concludes
Feb 06 2026
Barron's
SpyGlass Pharma and Agomab's Contrasting Nasdaq Debuts
Feb 06 2026
seekingalpha
SpyGlass Pharma and Agomab IPO Pricing Announced
Feb 06 2026
seekingalpha
AgomAb Therapeutics Raises $200 Million in IPO for Fibrotic Disorder Therapies
Feb 06 2026
renaissancecapital
Agomab Therapeutics Prices IPO at $16 per ADS
Feb 06 2026
Newsfilter
AGOMAB ANTICIPATES GROSS PROCEEDS OF $200.0 MILLION
Feb 06 2026
moomoo
AGOMAB: SETS PRICE FOR 12.5 MILLION ADS AT $16.00 EACH
Feb 06 2026
moomoo
AGOMAB REVEALS PRICING FOR ITS INITIAL PUBLIC OFFERING
Feb 06 2026
moomoo
Show More News
